Kurm Pharma ApS — Credit Rating and Financial Key Figures

Kurm Pharma ApS (CVR number: 39181274) is a company from VEJLE. The company recorded a gross profit of 331.1 kDKK in 2024. The operating profit was 279.1 kDKK, while net earnings were 602.2 kDKK. The profitability of the company measured by Return on Assets (ROA) was 13.2 %, which can be considered good but Return on Equity (ROE) was 15.9 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 59.6 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. Kurm Pharma ApS's liquidity measured by quick ratio was 2.5 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.